# A 6-month Study to Evaluate Sulforaphane Effects in PD Patients

> **NCT05084365** · PHASE2 · UNKNOWN · sponsor: **Central South University** · enrollment: 100 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Sulforaphane
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05084365
- **Lead sponsor:** Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-28
- **Primary completion:** 2023-11-15
- **Final completion:** 2023-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05084365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05084365, "A 6-month Study to Evaluate Sulforaphane Effects in PD Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05084365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*